Stay updated on BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial
Sign up to get notified when there's something new on the BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial page.

Latest updates to the BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial page
- Check2 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a small backend or template update with no visible changes to the study information.SummaryDifference0.0%

- Check9 days agoChange DetectedThe study’s locations were expanded with new sites in the UK, Turkey, South Africa, India, Argentina, and the US, and the total number of locations increased to 200. The record also shows completion with actual dates and an enrollment of 957.SummaryDifference0.7%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.6.3 is now shown, replacing Revision: v3.6.2. This reflects a newer version of the study page, a metadata update rather than a change to trial content.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page shows a new revision label (v3.6.2) indicating an updated version of the study record. Substantive content appears unchanged.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page now clearly indicates that recruitment has ended, and it adds new user help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating a study heading (Intervention/Treatment) and adopting a new Revision: v3.6.0.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a minor version update with no specified user-visible content changes.SummaryDifference0.0%

Stay in the know with updates to BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial page.